Anti-Adipogenic Effect of Secondary Metabolites Isolated from Tetracera loureiri on 3T3-L1 Adipocytes
Open Access
- 29 January 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1374
Abstract
A species of the genus Tetracera has been used as herbal medicine in traditional Indian Tetracera loureiri medicine. Tetracera loureiri, a plant from the Dilleniaceae family is considered one of the most valuable herbs in Thailand and is native to Southeast Asia. However, the anti-obesity effects of Tetracera loureiri extract have not been reported. In this study, we screened the effect of EtOH extract on lipid accumulation in a 3T3-L1 adipocyte model at various concentrations using Oil Red O staining, and the results were visualized under a light microscope. The fractionation of the soluble CH2Cl2 and EtOAc fractions from the EtOH extract revealed that both fractions significantly inhibited lipid accumulation in adipocytes at 2.5, 5, and 10 μg/mL, compared to n-hexane, n-BuOH, and aqueous extracts. Bioactivity-guided fractionation of the CH2Cl2 and EtOAc extract led to the phytochemical investigation of 10 secondary metabolites (1–10), and the structure of these compounds was identified using various spectroscopic methods. All isolated compounds were evaluated for their ability to inhibit adipogenesis at a concentration of 2.5, 5, and 10 μM compared with positive control (Orlistat 100 μg/mL); in particular, compounds 1–3, 5, and 7–8 showed 57.39 ± 6.98, 19.35 ± 4.53%, 75.81 ± 1.75%, 17.61 ± 1.62%, 19.83 ± 5.27 and 14.66 ± 3.85% reduction in fat accumulation at 10 μMm in 3T3-L1 adipocytes, respectively. The activity of these compounds also inhibited the secretion of adiponectin and leptin in 3T3-L1 adipocytes, suggesting their role in disrupting adipocyte function and metabolic regulation. Therefore, the results herein provide experimental evidence supporting the potential of Tetracera loureiri extracts as an anti-obesity therapeutic agent.Keywords
Funding Information
- National Institute of Biological Resources (NIBR202406202)
- National Institute of Biological Resources (NIBR202506102)
This publication has 43 references indexed in Scilit:
- Controlled lipid digestion in the development of functional and personalized foods for a tailored delivery of dietary fatsFood Chemistry, 2024
- The effect of quercetin on adipogenesis, lipolysis, and apoptosis in 3T3‐L1 adipocytes: The role of SIRT1 pathwaysObesity Science & Practice, 2024
- Pharmacotherapy of obesity: an update on the available medications and drugs under investigationeClinicalMedicine, 2023
- The activity comparison of six dietary flavonoids identifies that luteolin inhibits 3T3-L1 adipocyte differentiation through reducing ROS generationThe Journal of Nutritional Biochemistry, 2022
- Acylated Triterpenoids, Flavonoids, and Lignans Isolated from the Stems of Tetracera loureiriChemistry of Natural Compounds, 2019
- Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase ABioorganic Chemistry, 2019
- Corosolic acid inhibits adipose tissue inflammation and ameliorates insulin resistance via AMPK activation in high-fat fed micePhytomedicine, 2016
- A review of the dietary flavonoid, kaempferol on human health and cancer chemopreventionFood Chemistry, 2013
- The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathwaysBiochemical and Biophysical Research Communications, 2008
- Hepatoprotective and antioxidant activities of Tetracera loureiriPhytotherapy Research, 2003